The role of interleukin-1 in wound biology. part II: In vivo and human translational studies

Anesthesia and Analgesia

Volumn 111, Issue 6, 2010, Pages 1534-1542

  Hu, Yajing ^a   Liang, Deyong ^b   Li, Xiangqi ^b   Liu, Hong Hsing ^a   Zhang, Xun ^c   Zheng, Ming ^a   Dill, David ^d   Shi, Xiaoyou ^b   Qiao, Yanli ^a   Yeomans, David ^a   Carvalho, Brendan ^a   Angst, Martin S ^a   Clark, J David ^b   Peltz, Gary ^a  

^a STANFORD UNIVERSITY   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c Roche Palo Alto ^*  (United States)

^d Stanford University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMGEN; CHEMOKINE; CXCL1 CHEMOKINE; CXCL9 CHEMOKINE; EOTAXIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; KERATINOCYTE DERIVED CHEMOKINE; LEPTIN; LYMPHOTOXIN; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; NERVE GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BB; PROSTAGLANDIN E2; RANTES; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; MALE; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; SURGICAL WOUND; ULTRAVIOLET B RADIATION; WOUND HEALING;

ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELLS, CULTURED; CESAREAN SECTION; CHEMOKINE CCL3; CHEMOKINE CXCL1; CHEMOKINES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; INTERLEUKIN-8; KERATINOCYTES; MALE; MICE; MICE, INBRED C57BL; PAIN, POSTOPERATIVE; PREGNANCY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SKIN; SUNBURN; TIME FACTORS; TRANSLATIONAL RESEARCH; WOUND HEALING;

EID: 78650308735     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e3181f691eb     Document Type: Article

References (46)

1. Hu Y, Liang D, Li X, Liu H-H, Zhang X, Zheng M, Dill D, Shi X, Qiao Y, Yeomans D, Carvalho B, Angst MS, Clark JD, Peltz G. The role of interleukin-1 in wound biology. Part I: Murine in silico and in vitro experimental analysis. Anesth Analg 2010;111:1525-33
2. Pogatzki EM, Raja SN. A mouse model of incisional pain. Anesthesiology 2003;99:1023-7
3. Mertens M, Singh JA. Anakinra for rheumatoid arthritis: a systematic review. J Rheumatol 2009;36:1118-25
4. Fleischmann RM, Tesser J, Schiff MH, Schechtman J, Burmester GR, Bennett R, Modafferi D, Zhou L, BellD, Appleton B. Safety of extended treatment with anakinra in patients with rheuma-toid arthritis. Ann Rheum Dis 2006;65:1006-12
5. Liang D, Liao G, Wang J, Usuka J, Guo YY, Peltz G, Clark JD. A genetic analysis of opioid-induced hyperalgesia in mice. Anesthesiology 2006;104:1054-62
6. Englelhardt E, Toksoy A, Goebeler M, Debus S, Brocker EB, Gillitzer R. Chemokines IL-8, GROalpha, MCP-1, IP-10, and Mig are sequentially and differentially expressed during phase-specific infiltration of leukocyte subsets in human wound healing. Am J Pathol 1998;153:1849-60
7. Carvalho B, Clark DJ, Yeomans DC, Angst MS. Continuous subcutaneous instillation of bupivacaine compared to saline reduces interleukin 10 and increases substance P in surgical wounds after cesarean delivery. Anesth Analg 2010;111:1452-9
8. Carvalho B, Clark DJ, Angst MS. Local and systemic release of cytokines, nerve growth factor, prostaglandin E2, and sub-stance P in incisional wounds and serum following cesarean delivery. J Pain 2008;9:650-7
9. Carvalho B, Clark DJ, Yeomans D, Angst MS. Collecting and measuring nociceptive and inflammatory mediators in surgical wounds. J Vis Exp 2008 Oct 29;(20). pii: 962. doi: 10.3791/962
10. Rodgers JL, Nicewander WA. Thirteen ways to look at the correlation coefficient. Am Statistician 1988;42:59-66
11. Hollander M, Wolfe DA. Nonparametric Statistical Methods. New York: John Wiley & Sons, 1973
12. Feldmeyer L, Keller M, Niklaus G, HohlD, Werner S, Beer HD. The inflammasome mediates UVB-induced activation and se-cretion of interleukin-1beta by keratinocytes. Curr Biol 2007;17:1140-5
13. Angst MS, Clark JD, Carvalho B, Tingle M, Schmelz M, Yeomans DC Cytokine profile in human skin in response to experimental inflammation, noxious stimulation, and administration of a COX-inhibitor: a microdialysis study. Pain 2008;139:15-27
14. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc Ser B 1995;57:289-300
15. Wolf G, Livshits D, Beilin B, Yirmiya R, Shavit Y. Interleukin-1 signaling is required for induction and maintenance of post-operative incisional pain: genetic and pharmacological studies in mice. Brain Behav Immun 2008;22:1072-7
16. Binshtok AM, Wang H, Zimmermann K, Amaya F, Vardeh D, Shi L, Brenner GJ, Ji RR, Bean BP, Woolf CJ, Samad TA. Nociceptors are interleukin-1beta sensors. J Neurosci 2008;28:14062-73
17. Verri WA Jr, Cunha TM, Parada CA, Poole S, Cunha FQ, Ferreira SH. Hypernociceptive role of cytokines and chemo-kines: targets for analgesic drug development? Pharmacol Ther 2006;112:116-38
18. Cunha TM, Verri WA Jr, Silva JS, Poole S, Cunha FQ, Ferreira SH. A cascade of cytokines mediates mechanical inflammatory hypernociception in mice. Proc Natl Acad Sci USA 2005;102:1755-60
19. Niethammer P, Grabher C, Look AT, Mitchison TJ. A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish. Nature 2009;459:996-9
20. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, Brohi K, Itagaki K, Hauser CJ. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010;464:104-7
21. Lee P, Lee DJ, Chan C, Chen SW, Ch'en I, Jamora C. Dynamic expression of epidermal caspase 8 simulates a wound healing response. Nature 2009;458:519-23
22. Watanabe H, Gaide O, Petrilli V, Martinon F, Contassot E, Roques S, Kummer JA, Tschopp J, French LE. Activation of the IL-1beta-processing inflammasome is involved in contact hy-persensitivity. J Invest Dermatol 2007;127:1956-63
23. Yang BB, Baughman S, Sullivan JT. Pharmacokinetics of anak-inra in subjects with different levels of renal function. Clin Pharmacol Ther 2003;74:85-94
24. Thomay AA, Daley JM, Sabo E, Worth PJ, Shelton LJ, Harty MW, Reichner JS, Albina JE. Disruption of interleukin-1 sig-naling improves the quality of wound healing. Am J Pathol 2009;174:2129-36
25. Ishida Y, Kondo T, Kimura A, Matsushima K, Mukaida N. Absence of IL-1 receptor antagonist impaired wound healing along with aberrant NF-kappaB activation and a reciprocal suppression of TGF-beta signal pathway. J Immunol 2006;176:5598-606
26. Zhang X, Kohli M, Zhou Q, Graves DT, Amar S. Short-and long-term effects of IL-1 and TNF antagonists on periodontal wound healing. J Immunol 2004;173:3514-23
27. Wilusz RE, Weinberg JB, Guilak F, McNulty AL. Inhibition of integrative repair of the meniscus following acute exposure to interleukin-1 in vitro. J Orthop Res 2008;26:504-12
28. Genovese MC, Cohen S, Moreland L, Lium D, Robbins S, Newmark R, Bekker P. Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with metho-trexate. Arthritis Rheum 2004;50:1412-9
29. Martinelli I, Bucciarelli P, Mannucci PM. Thrombotic risk factors: basic pathophysiology. Crit Care Med 2010;38:S3-9
30. Hahn CL, Best AM, Tew JG. Rapid tissue factor induction by oral streptococci and monocyte-IL-1beta. J Dent Res 2007;86:255-9
31. Kambas K, Markiewski MM, Pneumatikos IA, Rafail SS, The-odorou V, Konstantonis D, Kourtzelis I, Doumas MN, Magotti P, Deangelis RA, Lambris JD, Ritis KD. C5a and TNF-alpha up-regulate the expression of tissue factor in intra-alveolar neutrophils of patients with the acute respiratory distress syndrome. J Immunol 2008;180:7368-75
32. Mackman N. Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol 2004;24:1015-22
33. Hu JY, Liang D, Li X, Liu H-H, Zhang X, Zheng M, Dill D, Shi X, Qiao Y, Yeomans D, Carvalho B, Angst MS, Clark JD, Peltz G. The role of interleukin-1 in wound biology. Part II. In vivo and human translational studies. Anesth Analg 2010;111:1534-42
34. Li WW, Guo TZ, Liang D, Shi X, Wei T, Kingery WS, Clark JD. The NALP1 inflammasome controls cytokine production and nociception in a rat fracture model of complex regional pain syndrome. Pain 2009;147:277-86
35. Newman S, Stygall J, Hirani S, Shaefi S, Maze M. Postoperative cognitive dysfunction after noncardiac surgery: a systematic review. Anesthesiology 2007;106:572-90
36. Hailer NP, Vogt C, Korf HW, Dehghani F. Interleukin-1beta exacerbates and interleukin-1 receptor antagonist attenuates neuronal injury and microglial activation after excitotoxic damage in organotypic hippocampal slice cultures. Eur J Neu-rosci 2005;21:2347-60
37. Sanderson KL, Raghupathi R, Saatman KE, Martin D, Miller G, McIntosh TK. Interleukin-1 receptor antagonist attenuates re-gional neuronal cell death and cognitive dysfunction after experimental brain injury. J Cereb Blood Flow Metab 1999;19:1118-25
38. Terrando N, Rei Fidalgo A, Vizcaychipi MP, Cibelli M, Ma D, Monaco C, Feldmann M, Maze M. The impact of IL-1 modu-lation on the development of lipopolysaccharide-induced cog-nitive dysfunction. Crit Care 2010;14:R88
39. Inoue A, Ikoma K, Morioka N, Kumagai K, Hashimoto T, Hide I, Nakata Y. Interleukin-1beta induces substance P release from primary afferent neurons through the cyclooxygenase-2 sys-tem. J Neurochem 1999;73:2206-13
40. Samad TA, Moore KA, Sapirstein A, Billet S, Allchorne A, Poole S, Bonventre JV, Woolf CJ. Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 2001;410:471-5
41. Safieh-Garabedian B, Poole S, Allchorne A, Winter J, Woolf CJ. Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hy-peralgesia. Br J Pharmacol 1995;115:1265-75
42. Kawasaki Y, Zhang L, Cheng JK, Ji RR. Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J Neurosci 2008;28:5189-94
43. Wannamaker W, Davies R, Namchuk M, Pollard J, Ford P, Ku G, Decker C, Charifson P, Weber P, Germann UA, Kuida K, Randle JC (S)-1-((S)-2-{[1-(4-amino- 3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoyl)-pyrrolidine-2- carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an orally available selective interleukin (IL)-converting enzyme/caspase-1 inhibitor, exhibits potent anti-inflammatory activities by inhibit-ing the release of IL-1beta and IL-18. J Pharmacol Exp Ther 2007;321:509-16
44. Zhang Q, Itagaki K, Hauser CJ. Mitochondrial DNA is released by shock and activates neutrophils via p38 Map-kinase. Shock 2010;34:55-9
45. Angst MS, Tingle M, Phillips NG, Carvalho B. Determining heat and mechanical pain threshold in inflamed skin of human subjects. J Vis Exp 2009 Jan 14; (23). pii: 1092. doi: 10.3791/1092
46. Carvalho B, Aleshi P, Horstman D, Angst M. The effect of a preemptive femoral nerve block on cytokine release and pain in inflamed skin of human volunteers. Reg Anesth Pain Med (in press)